摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-[5-(5,5-dimethyl-[1,3]dioxan-2-yl)-2-(4-fluoro-phenyl)-2H-[1,2,4]triazol-3-yl]-pyridine | 276683-90-0

中文名称
——
中文别名
——
英文名称
4-[5-(5,5-dimethyl-[1,3]dioxan-2-yl)-2-(4-fluoro-phenyl)-2H-[1,2,4]triazol-3-yl]-pyridine
英文别名
4-[5-(5,5-Dimethyl-1,3-dioxan-2-yl)-2-(4-fluorophenyl)-1,2,4-triazol-3-yl]pyridine
4-[5-(5,5-dimethyl-[1,3]dioxan-2-yl)-2-(4-fluoro-phenyl)-2H-[1,2,4]triazol-3-yl]-pyridine化学式
CAS
276683-90-0
化学式
C19H19FN4O2
mdl
——
分子量
354.384
InChiKey
CLIIYXPXCFFZEK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3
  • 重原子数:
    26
  • 可旋转键数:
    3
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.32
  • 拓扑面积:
    62.1
  • 氢给体数:
    0
  • 氢受体数:
    6

文献信息

  • Heteroaryl-cyclic acetals
    申请人:Collis Alan
    公开号:US20050090501A1
    公开(公告)日:2005-04-28
    Compounds of formula (I) are described in which Het is a five or six membered heteroaromatic ring of the formula in which one of R 1 and R 2 is optionally substituted heteroaryl and the other is optionally substituted heteroaryl or optionally substituted aryl; X 1 is a bond, X 3 and X 4 are each independently N or C and X 2 and X 5 are independently CH, N, NH, O or S; or X 3 and X 4 are C, one of X 1 , X 2 and X 5 is N and the others are N or CH; but excluding compounds in which X 1 is a bond, one of X 2 and X 5 is N and the other is NH and X 3 and X 4 are both C; R 3 represents a group -L 1 -R 6 ; R 4 represents hydrogen, alkyl or hydroxyalkyl; or R 3 and R 4 , when attached to the same carbon atom, may form with the said carbon atom a cycloalkyl, cycloalkenyl or heterocycloalkyl ring or a group C═CH 2 ; R 5 represents hydrogen or alkyl; and m is zero or an integer 1 or 2; and N-oxides thereof, and their prodrugs; and pharmaceutically acceptable salts and solvates of compounds of formula (I) and N-oxides thereof, and their prodrugs. The compounds are TNF inhibitors and are useful as pharmaceuticals.
    描述了式(I)化合物,其中Het是式的五元或六元杂环芳香环:其中R1和R2中的一个是可选取代的杂芳基,另一个是可选取代的杂芳基或可选取代的芳基;X1是键,X3和X4分别独立地是N或C,X2和X5独立地是CH、N、NH、O或S;或者X3和X4是C,X1、X2和X5中的一个是N,其他是N或CH;但不包括其中X1是键,X2和X5中的一个是N,另一个是NH,X3和X4都是C的化合物;R3表示一个-L1-R6基团;R4表示氢、烷基或羟基烷基;或者当附加到同一个碳原子时,R3和R4可以与所述碳原子形成环状烷基、环状烯基或杂环烷基环或C═CH2基团;R5表示氢或烷基;m为零或整数1或2;以及其N-氧化物和其前药;化合物的式(I)和其N-氧化物的药学上可接受的盐和溶剂;这些化合物是TNF抑制剂,可用于制药。
  • HETEROARYL-CYCLIC ACETALS
    申请人:Aventis Pharma Limited
    公开号:EP1140916B1
    公开(公告)日:2002-11-13
  • US7479501B2
    申请人:——
    公开号:US7479501B2
    公开(公告)日:2009-01-20
  • [EN] HETEROARYL-CYCLIC ACETALS<br/>[FR] ACETALS HETEROARYL-CYCLIQUES
    申请人:RHONE POULENC RORER LTD
    公开号:WO2000035911A1
    公开(公告)日:2000-06-22
    Compounds of formula (I) are described in which Het is a five or six membered heteroaromatic ring of formula (i) in which one of R?1 and R2¿ is optionally substituted heteroaryl and the other is optionally substituted heteroaryl or optionally substituted aryl; X1 is a bond, X?3 and X4¿ are each independently N or C and X?2 and X5¿ are independently CH, N, NH, O or S; or X?3 and X4¿ are C, one of X?1, X2 and X5¿ is N and the others are N or CH; but excluding compounds in which X1 is a bond, one of X?2 and X5¿ is N and the other is NH and X?3 and X4¿ are both C; R3 represents a group -L?1-R6; R4¿ represents hydrogen, alkyl or hydroxyalkyl; or R?3 and R4¿, when attached to the same carbon atom, may form with the said carbon atom a cycloalkyl, cycloalkenyl or heterocycloalkyl ring or a group C=CH¿2; R?5 represents hydrogen or alkyl; and m is zero or an integer 1 or 2; and N-oxides thereof, and their prodrugs; and pharmaceutically acceptable salts and solvates of compounds of formula (I) and N-oxides thereof, and their prodrugs. The compounds are TNF inhibitors and are useful as pharmaceuticals.
查看更多

同类化合物

(S)-氨氯地平-d4 (R,S)-可替宁N-氧化物-甲基-d3 (R)-(+)-2,2'',6,6''-四甲氧基-4,4''-双(二苯基膦基)-3,3''-联吡啶(1,5-环辛二烯)铑(I)四氟硼酸盐 (R)-N'-亚硝基尼古丁 (R)-DRF053二盐酸盐 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (2S,2'S)-(-)-[N,N'-双(2-吡啶基甲基]-2,2'-联吡咯烷双(乙腈)铁(II)六氟锑酸盐 (2S)-2-[[[9-丙-2-基-6-[(4-吡啶-2-基苯基)甲基氨基]嘌呤-2-基]氨基]丁-1-醇 (2R,2''R)-(+)-[N,N''-双(2-吡啶基甲基)]-2,2''-联吡咯烷四盐酸盐 (1'R,2'S)-尼古丁1,1'-Di-N-氧化物 黄色素-37 麦斯明-D4 麦司明 麝香吡啶 鲁非罗尼 鲁卡他胺 高氯酸N-甲基甲基吡啶正离子 高氯酸,吡啶 高奎宁酸 马来酸溴苯那敏 马来酸氯苯那敏-D6 马来酸左氨氯地平 顺式-双(异硫氰基)(2,2'-联吡啶基-4,4'-二羧基)(4,4'-二-壬基-2'-联吡啶基)钌(II) 顺式-二氯二(4-氯吡啶)铂 顺式-二(2,2'-联吡啶)二氯铬氯化物 顺式-1-(4-甲氧基苄基)-3-羟基-5-(3-吡啶)-2-吡咯烷酮 顺-双(2,2-二吡啶)二氯化钌(II) 水合物 顺-双(2,2'-二吡啶基)二氯化钌(II)二水合物 顺-二氯二(吡啶)铂(II) 顺-二(2,2'-联吡啶)二氯化钌(II)二水合物 韦德伊斯试剂 非那吡啶 非洛地平杂质C 非洛地平 非戈替尼 非布索坦杂质66 非尼拉朵 非尼拉敏 雷索替丁 阿雷地平 阿瑞洛莫 阿扎那韦中间体 阿培利司N-6 阿伐曲波帕杂质40 间硝苯地平 间-硝苯地平 镉,二碘四(4-甲基吡啶)- 锌,二溴二[4-吡啶羧硫代酸(2-吡啶基亚甲基)酰肼]-